Literature DB >> 9510469

Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers.

M Emi1, M Matsushima, T Katagiri, M Yoshimoto, F Kasumi, T Yokota, T Nakata, Y Miki, Y Nakamura.   

Abstract

To detect BRCA1 mutations in Japanese breast cancer patients, we screened 1,000 unselected primary cancers for mutations in exon 11, which accounts for 61% of the entire BRCA1 coding sequence. Using a method based on multiplex single-strand conformational polymorphism (SSCP) analysis of multiple restriction fragments generated by restriction-enzyme digestion of amplified DNA, we identified eight mutations. All eight were germline mutations; four of them were non-sense mutations or small deletions resulting in premature stop codons, and the other four were missense mutations. The Japanese carriers of these mutant BRCA1 alleles had developed breast cancers at ages ranging from 45 to 62, five of them bilaterally.

Entities:  

Mesh:

Year:  1998        PMID: 9510469      PMCID: PMC5921586          DOI: 10.1111/j.1349-7006.1998.tb00472.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


polymerase chain reaction single‐strand conformation polymorphism
  17 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

Authors:  B Newman; M A Austin; M Lee; M C King
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine delta-aminotransferase gene.

Authors:  J Michaud; L C Brody; G Steel; G Fontaine; L S Martin; D Valle; G Mitchell
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

4.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Authors:  L H Castilla; F J Couch; M R Erdos; K F Hoskins; K Calzone; J E Garber; J Boyd; M B Lubin; M L Deshano; L C Brody
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

6.  Familial ovarian cancer: a population-based case-control study.

Authors:  J M Schildkraut; W D Thompson
Journal:  Am J Epidemiol       Date:  1988-09       Impact factor: 4.897

7.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Authors:  D Shattuck-Eidens; M McClure; J Simard; F Labrie; S Narod; F Couch; K Hoskins; B Weber; L Castilla; M Erdos
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

8.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Germline mutation of BRCA1 in Japanese breast cancer families.

Authors:  R Inoue; T Fukutomi; T Ushijima; Y Matsumoto; T Sugimura; M Nagao
Journal:  Cancer Res       Date:  1995-08-15       Impact factor: 12.701

10.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

View more
  7 in total

1.  Multiplex, fluorescent single-strand conformation polymorphism using stepped polymerase chain reaction primers.

Authors:  R Scholl; A Walker; L W Ballard
Journal:  J Biomol Tech       Date:  2001-03

2.  The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.

Authors:  A Pemov; H Li; R Patidar; N F Hansen; S Sindiri; S W Hartley; J S Wei; A Elkahloun; S C Chandrasekharappa; J F Boland; S Bass; J C Mullikin; J Khan; B C Widemann; M R Wallace; D R Stewart
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

3.  Performance of BRCA1/2 mutation prediction models in Asian Americans.

Authors:  Allison W Kurian; Gail D Gong; Nicolette M Chun; Meredith A Mills; Ashley D Staton; Kerry E Kingham; Beth B Crawford; Robin Lee; Salina Chan; Susan S Donlon; Yolanda Ridge; Karen Panabaker; Dee W West; Alice S Whittemore; James M Ford
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

Review 4.  Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer.

Authors:  Haeyoung Kim; Doo Ho Choi
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

5.  Contribution of BRCA1 germline mutation in patients with sporadic breast cancer.

Authors:  Fraz A Malik; Saima Ashraf; Mahmood A Kayani; Wen G Jiang; A Mir; M Ansar; Ishraat A Baloch; Rafshan Sadiq
Journal:  Int Semin Surg Oncol       Date:  2008-08-29

6.  BRCA1 and BRCA2 Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan.

Authors:  Ainur R Akilzhanova; Bagdat Nyshanbekkyzy; Zhannur M Nurkina; Ivan I Shtephanov; Abay K Makishev; Tasbolat A Adylkhanov; Tolebay K Rakhypbekov; Erlan M Ramanculov; Kuvat T Momynaliev
Journal:  Cent Asian J Glob Health       Date:  2013-05-21

7.  Nonsense mutation at codon 63 of the BRCA1 gene in Japanese breast cancer patients.

Authors:  G Kijima; Y Murakami; N Ohuchi; S Satomi; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1998-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.